Lyell Immunopharma vs Smart Immune
Lyell Immunopharma
At Lyell, we are advancing next-generation CAR T-cell product candidates for patients with cancer
229 employees · est. 2018 · South San Francisco, United...
Smart Immune
Pioneering thymus-empowered T-cell platform to fight cancer and infection
35 employees · est. 2017 · Paris, France
Smart Immune is the older company (2018 vs 2017); Lyell Immunopharma is the larger of the two.
Side-by-Side Comparison
| Metric | Lyell Immunopharma | Smart Immune |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2017 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Paris, France |
| Employees | ||
| Employees | 229 larger | 35 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Grant |
| Total Funding | ||
| Total Funding | $968.00M | $25.30M |
| Funding Rounds | ||
| Funding Rounds | 6 | 5 |
| Services | ||
| Services | Development of Next-Generation CAR T-Cell Product Candidates, Cancer Cell Killing Capabilities, Clinical-Stage Research and Development, Advanced Manufacturing and Supply Chain Management, Cancer Target Identification | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer Patients, Healthcare Providers, Medical Researchers, Oncologists, Healthcare Institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | CAR T-cell TherapiesCancer TreatmentCell TherapyClinical Stage BiotechnologyT-cell BiologyImmunotherapy +9 | Cell TherapyCAR TImmuno-oncologyNK CellsT CellsImmune Reconstitution +8 |
| Website | ||
| Website | lyell.com | smart-immune.com |
About Lyell Immunopharma
Lyell Immunopharma, a United States-based biotechnology firm, is pioneering the development of next-generation CAR T-cell therapies aimed at cancer treatment. Founded in 2018 by cell therapy pioneers, the company leverages cutting-edge technology to enhance T cells with characteristics of resistance...
About Smart Immune
Smart Immune is a French biotechnology startup with a mission to revolutionize treatment outcomes for cancer and infectious diseases. Founded in 2017, the company is focused on developing ProTcell, a groundbreaking thymus-empowered T cell progenitor platform. This innovative technology aims to rapid...
Also comparing in this category
Comparing more than these two?
Get Lyell Immunopharma, Smart Immune and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Lyell Immunopharma compare?
A PDF of Lyell Immunopharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Lyell Immunopharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Lyell Immunopharma on 16 Jun 2026, and Smart Immune on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
